Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2008
11/26/2008CN101310725A Medicine composition for treating all kinds of cancer ache
11/26/2008CN101310723A Use of compounds that are effective as selective opiate receptor modulators
11/26/2008CN101310719A Combination chemotherapy
11/26/2008CN101310717A Tanshinone óA polylactic acid nano particles and preparation method thereof
11/26/2008CN101310714A Use of retinol X receptor used for screening alkannin and derivates thereof
11/26/2008CN101310622A Method for preparing microbial fat with low-content non saponifying objects and the fat
11/26/2008CN100437109C Method for controlling quality of injection for treating tumor
11/26/2008CN100436595C Method for diagnosis and treatment of hair eipidermal tumor using human's CYLD gene and its coded products
11/26/2008CN100436481C Targeted anti-tumour fused protein containing adenovirus E40rf4 protein
11/26/2008CN100436462C Reaction method of biological alkali, reaction product and use thereof
11/26/2008CN100436457C N1,N8-disubstituent-triethyl tetramine copper (II) complex and its prepn process
11/26/2008CN100436454C Novel harringtonlne derivative, method for making same and its pharmaceutical composition and use thereof
11/26/2008CN100436452C Pyrazole compounds useful as protein kinase inhibitors
11/26/2008CN100436450C Novel triarylimidazoles
11/26/2008CN100436443C Compound (2S)-5, 7.2', 6'-tetrahydroxy-6,8-diiso pentenyl-dihydro flavone extracting process and its use
11/26/2008CN100436439C Dimeric isoflavones
11/26/2008CN100436427C Aminobenzamide derivatives as glycogen synthase kinase 3 beta inhibitors
11/26/2008CN100436425C Fused imidazolium derivatives
11/26/2008CN100436418C N-Benzyl-3-indenylacetamides derivatives for treating neoplasia
11/26/2008CN100435850C Combination of medication produced from attenuated salmonella bacteria possessing effect of radiation protection and anti tumour
11/26/2008CN100435849C Anti-tumor agent using interleukin-23 gene
11/26/2008CN100435843C Compsns. of thymopentin and interferon
11/26/2008CN100435824C Detoxifying formulation containing astragalus root and greenbrier and preparation process thereof
11/26/2008CN100435814C Scullcap stem and leaf injection powder and its preparing method
11/26/2008CN100435808C Chinese medicine for treating dermatosis and tumor
11/26/2008CN100435802C Application of stauntoniae sapoin in preparation of anti-tumor medicine
11/26/2008CN100435799C Combination therapy
11/25/2008US7456333 Transgenic non-human mammals that reproduce human pathologies of stem cell origins, such as chromosomal anomalies associated with chronic myeloid leukemia, B-cell acute lymphoblastic leukemia, T-cell acute or lymphoblastic leukemia, or with the migration of hematopoietic or embryonic stem calls.
11/25/2008US7456302 Method for producing pentacyclic taxans
11/25/2008US7456294 Hairpin polyamide
11/25/2008US7456283 an N-phenyl-4-(4-methyl-piperazin-1-ylmethyl)-benzamide claimed intermediate easily prepared by amidation of the aniline and the benzoic acid; reaction with a 2-aminopyrimidine to produce antitumor tyrosine kinase inhibitor
11/25/2008US7456263 P53 binding T cell receptor molecules
11/25/2008US7456253 Growth hormone releasing peptides
11/25/2008US7456214 Cancer; for selectively destroying tumor vasculature; inhibit tubulin polymerization; selectively reducing blood flow to at least a portion of a neoplastic region; 3-(3',4',5'-Trimethoxybenzoyl)-6-hydroxy-7-methoxy-2H-chromene
11/25/2008US7456190 autoimmune disease; antiinflammatory agents; bone disorders; central nervous system disorders; cardiovascular disorders; Alzheimer's disease; antihistamines; antiallergens
11/25/2008US7456176 Benzotriazine inhibitors of kinases
11/25/2008US7456168 2-(pyridin-2-ylamino)-pyrido[2,3, d]pyrimidin-7-ones
11/25/2008US7456160 Sustained release; injection of fulvestrant; using 7 alpha -[9-(4,4,5,5,5-pentafluoropentylsulphinyl)nonyl]oestra-1,3,5(10)-triene-3,17 beta -diol to treat hormonal dependent benign or malignant disease of the breast or reproductive tract
11/25/2008US7456158 4-dedimethylaminotetracycline derivatives
11/25/2008US7456008 Modified virus comprising one or more non-native polypeptides
11/25/2008US7455986 Heparinase III and methods of specifically cleaving therewith
11/25/2008US7455964 Genes from the 20q13 amplicon and their uses
11/25/2008US7455855 Obtained by reacting polyalkylene glycol or a reactive derivative, a phospholipid and a drug with each other to form covalent bonds to form a delivery substance
11/25/2008US7455846 Immune potentiating compositions of cancer cells
11/25/2008US7455839 Method of inhibiting the formation of inhibin/betaglycan complexes with an anti-betaglycan antibody
11/25/2008US7455835 Administering soluble cytotoxic t-lymphocyte associated antigen (ctla4) molecule that binds a cell surface B7 molecule
11/25/2008US7455155 Impact absorbent assembly in slope protection systems
11/25/2008CA2433032C Sustained release drug delivery devices with coated drug cores
11/25/2008CA2421254C Methods for treating tumors using sulfonyl compounds
11/25/2008CA2414146C Substituted benzamides for immune enhancement and for the treatment of cancer, infection and manic-depressive illness
11/25/2008CA2375549C Delivery system for biological material
11/25/2008CA2361318C Novel nucleosides and oligonucleotide analogues
11/25/2008CA2345354C Antisense modulation of bcl-x expression
11/25/2008CA2322689C Substituted bisindolymaleimides for the inhibition of cell proliferation
11/25/2008CA2320182C Compositions containing organic compounds
11/25/2008CA2276606C Method of treating prostatic diseases using active vitamin d analogues
11/23/2008CA2590048A1 Cytosine nucleoside analogs and isoflavones and uses thereof
11/20/2008WO2008141145A1 Condensed heterocyclic compounds as inhibitors of protein kinases
11/20/2008WO2008141140A1 Condensed heterocyclic compounds as inhibitors of protein kinases
11/20/2008WO2008141114A1 Use of hdac inhibitors for the treatment of melanoma
11/20/2008WO2008141111A2 Polymers conjugated with platinum drugs
11/20/2008WO2008141110A2 Polyglutamate conjugates and polyglutamate-amino acid conjugates having a plurality of drugs
11/20/2008WO2008141107A2 Compositions that include a hydrophobic compound and a polyamino acid conjugate
11/20/2008WO2008141079A1 Tetrahydrofuro [3 4-d] dioxolane compounds for use in the treatment of viral infections and cancer
11/20/2008WO2008141044A2 Cysteine engineered anti-muc16 antibodies and antibody drug conjugates
11/20/2008WO2008140947A1 P70 s6 kinase inhibitors
11/20/2008WO2008140895A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
11/20/2008WO2008140850A1 Solid forms of a raf kinase inhibitor
11/20/2008WO2008140782A2 Compounds for enzyme inhibition
11/20/2008WO2008140724A1 Methods of treatment using intravenous formulations comprising temozolomide
11/20/2008WO2008140624A2 Methods and compositions related to hybird nanoparticles
11/20/2008WO2008140507A2 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
11/20/2008WO2008140421A2 Heterocycloalkyl substituted pyrimidine derivatives
11/20/2008WO2008140420A2 Pyrimidine derivatives
11/20/2008WO2008140419A2 Pyridyl substituted pyrimidine derivatives
11/20/2008WO2008140203A1 Phospholipid nanospheres for solubilization of diterpenoid alkaloid and preparation
11/20/2008WO2008140126A1 Single-stranded cyclic rna, and method for production thereof
11/20/2008WO2008140081A1 Liposome and method for producing liposome
11/20/2008WO2008139952A1 Microtubule-disrupting agent and cancer cell proliferation inhibitor containing the same
11/20/2008WO2008139938A1 Double-stranded nucleic acid molecule targeting for human papilloma virus type-16 gene, and pharmaceutical agent comprising the molecule
11/20/2008WO2008139483A1 Method and preparation of herbal extract of calotropis gigantea for cancer treatment
11/20/2008WO2008139241A1 Uses of north american ginseng fractions for treating leukemia
11/20/2008WO2008139202A1 Neutralizing monoclonal antibody against human dll4
11/20/2008WO2008139152A1 N-oxide-containing pharmaceutical compounds
11/20/2008WO2008139009A1 Pyridothieneotriazines as antiangiogenic compounds
11/20/2008WO2008138918A1 Mono-hydrochloric salts of an inhibitor of histone deacetylase
11/20/2008WO2008138904A2 Rna antagonist compounds for the modulation of her3
11/20/2008WO2008138889A2 3, 6-disubstituted-imidazo [1, 2-b] pyridazines and 3, 5-disubstituted pyrazolo[1, 5-a] pyrimidines as phosphatidylinositol-3-kinase inhibitors
11/20/2008WO2008138878A2 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
11/20/2008WO2008138834A1 Substituted imidazopyridazines as pi3k lipid kinase inhibitors
11/20/2008WO2008138658A2 Pharmaceutical compounds comprising abasic oligonucleotides
11/20/2008WO2008138615A1 Bicyclic and heterobicyclic derivatives, processes for preparing them and their uses
11/20/2008WO2008138594A1 Aryl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents
11/20/2008WO2008138591A2 Bicyclic and heterobicyclic derivatives,processes for preparing them and their uses
11/20/2008WO2008138561A1 Tubulysine derivatives
11/20/2008WO2008138516A1 (s,r)-3-phenyl-4,5 dihydro-5-isoxazole acetic acid-nitric oxide and use thereof as anti-cancer and antiviral agent
11/20/2008WO2008138232A1 Pyrrolo-nitrogenous heterocyclic derivatives, the preparation and the pharmaceutical use thereof
11/20/2008WO2008138214A1 A method for activation and expansion of lymphocytes with high efficiency and the culture sysytem thereof
11/20/2008WO2008138184A1 Derivatives of pyrroloazacycles, the method of making them and the use thereof as inhibitors of protein kinases
11/20/2008WO2008138139A1 Carbohydrate-containing pan cancer marker
1 ... 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 ... 2211